Advanced drug delivery platforms target cancer stem cells

Area of Science:

• Oncology
• Nanomedicine
• Cancer Biology

Background:

• Cancer stem cells (CSCs) are a distinct tumor subpopulation responsible for metastasis, recurrence, and treatment resistance.
• CSCs can enter dormancy, evading therapy and immune surveillance, leading to late-stage cancer recurrence.
• Targeting CSCs is crucial for improving patient survival and achieving durable remission.

Purpose of the Study:

• To review and classify emerging therapeutic strategies for targeting cancer stem cells.
• To highlight advancements in nanocarrier design and drug delivery for CSCs.
• To discuss the potential of these approaches in preclinical and clinical settings for recurrent cancer.

Main Methods:

• Classification of recent therapeutic approaches based on CSC biology and properties.
• Review of nanoparticle engineering, extracellular matrix modulation, and targeted delivery systems.
• Analysis of combined therapies involving nanomedicine and conventional treatments.

Main Results:

• Various strategies including nanoparticle engineering, cocktail therapies, and targeted approaches show potential for CSC elimination.
• Nanomedicine-based drug delivery systems demonstrate efficient targeting of CSCs when combined with traditional therapies.
• Preclinical and clinical trials are evaluating the efficacy of these advanced CSC-targeting methods.

Conclusions:

• Targeting CSCs via novel therapeutic strategies, particularly nanomedicine, offers a promising avenue for overcoming treatment resistance and recurrence.
• Further research and clinical translation of these approaches are essential for improving outcomes in challenging cancer cases.
• Eliminating CSCs is key to preventing cancer recurrence and enhancing long-term patient survival.